Bloodstream Infections Are an Improbable Cause of Positive Serum (1,3)-β-D-Glucan in Hematology Patients

被引：13
|
作者：
Furfaro, E. [1 ]
Mikulska, M. [1 ]
Del Bono, V. [1 ]
Guolo, F. [2 ]
Minetto, P. [2 ]
Gobbi, M. [2 ]
Ghiso, A. [3 ]
Bacigalupo, A. [3 ]
Viscoli, C. [1 ]
机构：
[1] IRCCS San Martino IST Univ Hosp, Div Infect Dis, Genoa, Italy
[2] IRCCS San Martino IST Univ Hosp, Div Hematol, Genoa, Italy
[3] IRCCS San Martino IST Univ Hosp, Div Hematol & HSCT, Genoa, Italy
来源：
CLINICAL AND VACCINE IMMUNOLOGY | 2014年 / 21卷 / 09期
关键词：
INVASIVE FUNGAL-INFECTIONS; BETA-D-GLUCAN; 1,3-BETA-D-GLUCAN ASSAY; PSEUDOMONAS-AERUGINOSA; EARLY-DIAGNOSIS; ASPERGILLOSIS; GALACTOMANNAN; MALIGNANCIES; PERFORMANCE; REACTIVITY;
D O I：
10.1128/CVI.00214-14
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Ninety-one serum samples from 51 hematology patients with bacteremia infections were tested for (1,3)-beta-D-glucan (BG). Eleven samples (15%) from 7 patients (14%) were positive for BG. Of these 7 patients with positive BG results, 4 (8%) had invasive aspergillosis and 3 (6%) had no invasive fungal disease. Bacteremia was an unlikely cause of the false-positive BG results.
引用
收藏
页码：1357 / 1359
页数：3
相关论文
共 50 条
  • [1] Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections
    Albert, O.
    Toubas, D.
    Strady, C.
    Cousson, J.
    Delmas, C.
    Vernet, V.
    Villena, I.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (11) : 1453 - 1460
  • [2] Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infections
    O. Albert
    D. Toubas
    C. Strady
    J. Cousson
    C. Delmas
    V. Vernet
    I. Villena
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 1453 - 1460
  • [3] Clinical Performance of the (1,3)-β-D-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections
    Del Bono, Valerio
    Delfino, Emanuele
    Furfaro, Elisa
    Mikulska, Malgorzata
    Nicco, Elena
    Bruzzi, Paolo
    Mularoni, Alessandra
    Bassetti, Matteo
    Viscoli, Claudio
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (12) : 2113 - 2117
  • [4] Prognostic Impact of Negative Serum (1,3)-β-D-glucan in Patients With Candidemia
    Giacobbe, Daniele Roberto
    Berruti, Marco
    Mikulska, Malgorzata
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 1124 - 1126
  • [5] Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients
    Giacobbe, Daniele Roberto
    Del Bono, Valerio
    Viscoli, Claudio
    Mikulska, Malgorzata
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2017, 15 (12) : 1101 - 1112
  • [6] Serum (1,3)-β-D-Glucan for Screening of Neonatal Fungemia
    Kamirul Islam
    Nazima Khatun
    Ujjal Mondal
    Kuntalkanti Das
    Kaustav Nayek
    Indian Pediatrics, 2022, 59 : 499 - 500
  • [7] Serum (1,3)-β-D-Glucan for Screening of Neonatal Fungemia
    Islam, Kamirul
    Khatun, Nazima
    Mondal, Ujjal
    Das, Kuntalkanti
    Nayek, Kaustav
    INDIAN PEDIATRICS, 2022, 59 (06) : 499 - 500
  • [8] Histoplasmosis as a cause for a positive Fungitell™ (1→3)-β-D-glucan test
    Egan, Lindsey
    Connolly, Patricia
    Wheat, L. Joseph
    Fuller, Deanna
    Davis, Thomas E.
    Knox, Kenneth S.
    Hage, Chadi A.
    MEDICAL MYCOLOGY, 2008, 46 (01) : 93 - 95
  • [9] Prognostic Impact of Negative Serum (1,3)-β-D-glucan in Patients With Candidemia Reply
    Agnelli, Caroline
    Valerio, Maricela
    Bouza, Emilio
    Munoz, Patricia
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 1126 - 1126
  • [10] Is initial serum (1,3)-β-D-glucan truly associated with mortality in patients with candidaemia?
    Abe, M.
    Kimura, M.
    Araoka, H.
    Taniguchi, S.
    Yoneyama, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (06) : 576 - 576
12345